SMITHKLINE BEECHAM CORP innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	1,933
#2	WIPO (World Intellectual Property Organization)	1,792
#3	EPO (European Patent Office)	1,695
#4	Australia	943
#5	Canada	712
#6	Japan	499
#7	South Africa	462
#8	United Kingdom	435
#9	China	424
#10	Mexico	300
#11	Israel	299
#12	Argentina	282
#13	New Zealand	280
#14	Brazil	266
#15	Norway	265
#16	Poland	224
#17	Hungary	197
#18	Czechia	194
#19	Taiwan	189
#20	Colombia	177
#21	Morocco	140
#22	Peru	130
#23	Hong Kong	128
#24	Portugal	117
#25	Republic of Korea	97
#26	Ireland	89
#27	African Regional Industrial Property Organization	77
#28	Slovakia	71
#29	Bulgaria	63
#30	Uruguay	57
#31	African Intellectual Property Organization	52
#32	Finland	48
#33	EAPO (Eurasian Patent Organization)	47
#34	Ukraine	43
#35	Algeria	41
#36	Malaysia	41
#37	Costa Rica	36
#38	Chile	33
#39	Indonesia	26
#40	Iceland	23
#41	Singapore	21
#42	Denmark	20
#43	Slovenia	19
#44	Saudi Arabia	17
#45	Ecuador	14
#46	Cyprus	13
#47	Egypt	13
#48	Romania	13
#49	Greece	10
#50	Zimbabwe	9
#51	Dominican Republic	7
#52	Spain	7
#53	India	7
#54	Luxembourg	7
#55	Jordan	6
#56	Netherlands	6
#57	Philippines	5
#58	Germany	3
#59	Gulf Cooperation Council	3
#60	Turkey	3
#61	Yugoslavia (Serbia and Montenegro)	3
#62	Switzerland	2
#63	Croatia	2
#64	Serbia	2
#65	France	1
#66	Monaco	1
#67	Russian Federation	1

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Peptides
#5	Acyclic or carbocyclic compounds
#6	Microorganisms
#7	Analysing materials
#8	Climate change adaptation technologies
#9	Unspecified technologies
#10	Measuring microorganism processes

Publication	Filing date	Title
AU2012202710A1	2012-05-09	Quinoline derivatives as P13 kinase inhibitors
US2010286041A1	2010-02-04	(5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
TW201035017A	2009-09-24	Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide
GB0915892D0	2009-09-10	Compounds
WO2010022308A1	2009-08-21	Prolyl hydroxylase inhibitors
WO2010025087A1	2009-08-21	Prolyl hydroxylase inhibitors
ZA200905693B	2009-08-17	Methods of treating cancer by administering human IL-18 combinations
WO2010018132A1	2009-08-07	Compounds
WO2010018134A1	2009-08-07	Novel adenine derivatives
WO2010018130A1	2009-08-07	Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
WO2010015653A1	2009-08-05	Pyrimidine derivatives as activators of soluble guanylate cyclase
WO2010011912A1	2009-07-24	Trpv4 antagonists
WO2010011914A1	2009-07-24	Trpv4 antagonists
WO2010011812A1	2009-07-23	Chemical compounds
WO2010011818A1	2009-07-23	Chemical compounds
WO2010011815A1	2009-07-23	Chemical compounds
WO2010011819A1	2009-07-23	Chemical compounds
WO2010005865A1	2009-07-02	Methods, apparatus and systems employing multiple energy sources for analyzing compositions
WO2009158315A1	2009-06-23	Prolyl hydroxylase inhibitors
WO2009147121A1	2009-06-02	Carboxyl substituted indoles for use as ppar alpha modulators